Dr. Sarwal’s clinical interests focus on personalizing transplant injury diagnostics for monitoring and therapuetic innovations for mmunosuppression drug design, inclusive of drug repositioning. She heads the BioX and ImmunoX affiliated Sarwal Lab, funded by the NIH, DOD and Chang Zuckerberg Initiative (CZI), where the lab also works on the application of single cell RNASeq, scATACSeq, MIBI, COSMx, TCR and BCRSeq, proteomics and CytoF technologies and their integrated computational analysis with patient clinical data.  She has over 300 peer reviewed publications and multiple book chapters, and is a Capstone Mentor for the Masters in Translational Medicine Program from UC Berkeley/UCSF, a T32 surgery training grant mentor, and as an active member, accepts PhD and MS candidates from the Baakar Computational Institue, ImmunoX and Human Genetics programs at UCSF.